Search

Search Results

• 

  The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial

  Bruno Giammusso, Rosaria Di Mauro, Renato Bernardini

  17-21

  2017-03-31

  Published: March 31, 2017

  4577

  PDF: 3476
• 

  A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III

  Giuseppe Morgia, Giorgio Ivan Russo, Daniele Urzì, Salvatore Privitera, Tommaso Castelli, Vincenzo Favilla, Sebastiano Cimino

  110-113

  2017-06-30

  Published: June 30, 2017

  4586

  PDF: 2573
• 

  Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis

  Ubaldo Cantoro, Francesco Catanzariti, Vito Lacetera, Luigi Quaresima, Giovanni Muzzonigro, Massimo Polito

  109-112

  2013-09-26

  Published: September 26, 2013

  2255

  PDF: 1611

• Psychological and sexological assessment of patients with chronic prostatitis

  Konstantinos Stamatiou, Vittorio Magri, Margherita Trinchieri, Alberto Trinchieri, Gianpaolo Perletti

  2024-03-26

  Published: March 26, 2024

  381

  PDF: 314
• 

  Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients

  Tommaso Cai, Daniele Tiscione, Luca Gallelli, Paolo Verze, Alessandro Palmieri, Vincenzo Mirone, Riccardo Bartoletti, Gianni Malossini

  177-182

  2016-10-05

  Published: October 5, 2016

  4065

  PDF: 2211
• 

  Chronic prostatitis as possible risk factor for Peyronie's disease (PD): psychological, sexual and prostatitis-like symptoms in patients with PD

  Gianni Paulis, Andrea Paulis

  2023-05-31

  Published: May 31, 2023

  1443

  PDF: 443

  Supplementary material: 55
• 

  The role of anticholinergic therapy based on the upoint system in the treatment of chronic prostatitis

  Kamil Fehmi Narter, Utku Can, Alper Coşkun, Kubilay Sabuncu, Fatih Tarhan

  16-21

  2019-03-29

  Published: March 29, 2019

  1356

  PDF: 782

• Efficacy of palmitoylethanolamide, epilobium and calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III

  Giuseppe Morgia, Arturo Lo Giudice, Maurizio Carrino, Salvatore Voce, Andrea Cocci, Giulio Reale, Andrea Minervini, Sebastiano Cimino, Giorgio Ivan Russo, Francesca Zingone

  2024-06-27

  Published: June 27, 2024

  1437

  PDF: 345
• 

  Lower urinary tract symptoms and mental health during COVID-19 pandemic

  Biagio Barone, Luigi De Luca, Luigi Napolitano, Pasquale Reccia, Felice Crocetto, Massimiliano Creta, Raffaele Vitale, Vincenzo Francesco Caputo, Raffaele Martino, Luigi Cirillo, Giovanni Maria Fusco, Massimiliano Trivellato, Giuseppe Celentano, Roberto La Rocca, Domenico Prezioso, Nicola Longo

  46-50

  2022-03-29

  Published: March 29, 2022

  1152

  PDF: 658
• 

  Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis

  Konstantinos Stamatiou, Vittorio Magri, Gianpaolo Perletti, Alberto Trinchieri, Richard Lacroix, Nektaria Rekleiti, Hippocrates Moschouris

  2019-07-02

  Published: July 2, 2019

  1645

  PDF: 1115